ALTYX SURGICAL, INC.

EVANSTON, IL · Medtech · Private

Non-mesh surgical device for stress urinary incontinence using elastic band, tissue anchor, and bone anchor components

Grants
$1.2M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
5
0 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · STTR Phase I: A mesh-free, sling-free, minimally invasive treatment for stress urinary incontinence in women$256,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II: A mesh-free, sling-free, minimally invasive treatment for stress urinary incontinence in women$975,713
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2085YEARONE LLC——
2086ACENXION BIOSYSTEMS INC——
2087ACOUSTIC MEDSYSTEMS, INC.——
2088ALTYX SURGICAL, INC.——
2089REDWOOD NEURO INC.——
2090CLEAR GENE INC——
2091PRIVO TECHNOLOGIES, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 5
  • Tissue-pexy Systems And Associated Devices And Methodsapplication
  • Systems And Methods For Diagnosing Rectal Support Defectsapplication
  • Suture-based Assembly For Tissue Repair, And Associated Devices And Methodsapplication
  • Suture-based Assembly For Tissue Repairapplication
  • Tissue Surface Piercing Systems And Methodsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.